Skip Navigation


Brain Advance Access originally published online on June 30, 2006
Brain 2006 129(12):3402-3412; doi:10.1093/brain/awl149
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/12/3402    most recent
awl149v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jeppesen, T. D.
Right arrow Articles by Vissing, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeppesen, T. D.
Right arrow Articles by Vissing, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy

Tina D. Jeppesen1, Marianne Schwartz2, David B. Olsen1, Flemming Wibrand2, Thomas Krag1, Morten Dunø2, Simon Hauerslev1 and John Vissing1

1 Department of Neurology, Neuromuscular Research Unit, The Copenhagen Muscle Research Centre Rigshospitalet, Copenhagen, Denmark 2 Department of Clinical Genetics, National University Hospital Rigshospitalet, Copenhagen, Denmark

Correspondence to: Tina Dysgaard Jeppesen, Neuromuscular Research Unit, section 7611, National University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark E-mail: dysgaard{at}rh.dk

Exercise intolerance is a prominent symptom in patients with mitochondrial myopathy (MM), but it is still unsettled whether exercise training is safe and beneficial for patients with MM. To address this, we studied the effect of 12 weeks cycle training on exercise capacity, quality of life and underlying molecular and cellular events in five patients with single large-scale deletions, one with a microdeletion and 14 with point mutations of mitochondrial DNA (mtDNA), and 13 healthy subjects. Each training session lasted 30 min, and was performed at an intensity of 70% of VO2max (maximal oxygen uptake). Each subject performed 50 training sessions in 12 weeks. All subjects were evaluated before and after training, and 13 MM patients were studied after 8 weeks of deconditioning. Evaluation included VO2max and mutation load and mtDNA quantity, mitochondrial enzymatic activity, and number of centrally nucleated, apoptotic, ragged red and cytochrome oxidase (COX)-negative fibres in muscle biopsies from the quadriceps muscle. After 12 weeks of training, VO2max and muscle citrate synthase increased in MM (26 and 67%) and healthy (17 and 65%) subjects, while mtDNA quantity in muscle only increased in the MM patients (81%). In the MM patients, training did not change mtDNA mutation load in muscle, mitochondrial enzyme complex activities, muscle morphology and plasma creatine kinase. After deconditioning, VO2max and citrate synthase activity returned to values before training, while muscle mtDNA mutation load decreased. These findings show that aerobic training efficiently improves oxidative capacity in MM patients. Based on unchanged levels of mutant load in muscle, morphological findings on muscle biopsy and plasma creatine kinase levels during training, the treatment appears to be safe. Regular, supervised aerobic exercise is therefore recommended in MM patients with the studied mutations.

Key Words: mitochondrial myopathy; training; mtDNA; mutation load

Abbreviations: CK, creatine kinase; HR, heart rate; MM, mitochondrial myopathy; mtDNA, mitochondrial DNA; RRF, ragged red fibres; VO2max, maximal oxygen uptake; Wmax, maximal workload

Received February 9, 2006. Revised April 27, 2006. Accepted May 3, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
T. Wenz, F. Diaz, D. Hernandez, and C. T. Moraes
Endurance exercise is protective for mice with mitochondrial myopathy
J Appl Physiol, May 1, 2009; 106(5): 1712 - 1719.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Preisler, G. Andersen, F. Thogersen, C. Crone, T. D. Jeppesen, F. Wibrand, and J. Vissing
Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)
Neurology, January 27, 2009; 72(4): 317 - 323.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. L. Murphy, E. L. Blakely, A. M. Schaefer, L. He, P. Wyrick, R. G. Haller, R. W. Taylor, D. M. Turnbull, and T. Taivassalo
Resistance training in patients with single, large-scale deletions of mitochondrial DNA
Brain, November 1, 2008; 131(11): 2832 - 2840.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
T Higashimoto, E E Baldwin, J I Gold, and R G Boles
Reflex sympathetic dystrophy: complex regional pain syndrome type I in children with mitochondrial disease and maternal inheritance
Arch. Dis. Child., May 1, 2008; 93(5): 390 - 397.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.